Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking Ep 246

Frankly Speaking About Family Medicine

Inhoud geleverd door Pri-Med. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Pri-Med of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

2+ y ago 9:21

MP3•Thuis aflevering

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246

Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients.

Episode resource links:

Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/

Guest: Jill M. Terrien PhD, ANP-BC

Music Credit: Richard Onorato

390 afleveringen

#Medicine #Continuingmedicaleducation #Familymedicine #Familypractice #Medical #Primarycare #Science #PriMed Podcasts #Podcasting Education